<!DOCTYPE html>
<html>
<head>
    <title>Monarch Models</title>
    {{#scripts}}
    <script type="text/javascript" src="{{url}}"></script>
    {{/scripts}}
    {{#stylesheets}}
    <link rel="stylesheet" type="text/css" href="{{url}}"></link>
    {{/stylesheets}}
    <link rel="stylesheet" type="text/css" href="../css/monarch-common.css"></link>
    <link rel="stylesheet" type="text/css" href="../css/monarch-main.css"></link>
    <meta charset=”utf-8”>
</head>
<body>
    {{{includes.navbar}}}
    <div class="container">
    <div class="sidebar">
        {{{includes.navlist}}}
    </div>
    <div class="content">
        <div class="jumbotron">
            <h1>Model spotlight: Fat Aussie</h1>
            <p>
            The biochemical differences between simple steatosis, a
            benign liver disease, and non-alcoholic steatohepatitis, which
            leads to cirrhosis, are unclear. Fat aussie is an obese mouse
            strain with a truncating mutation (foz) in the Alms1
            gene. Chow-fed female foz/foz mice develop obesity, diabetes,
            and simple steatosis. We fed foz/foz and wildtype mice a
            high-fat diet. Foz/foz mice developed serum ALT elevation and
            severe steatohepatitis with hepatocyte ballooning,
            inflammation, and fibrosis; wildtype mice showed simple
            steatosis. Biochemical pathways favoring hepatocellular lipid
            accumulation (fatty acid uptake; lipogenesis) and lipid
            disposal (fatty acid beta-oxidation; triglyceride egress) were
            both induced by high-fat feeding in wildtype but not foz/foz
            mice. The resulting extremely high hepatic triglyceride levels
            were associated with induction of mitochondrial uncoupling
            protein-2 and adipocyte-specific fatty acid binding protein-2,
            but not cytochrome P4502e1 or lipid peroxidation. In this
            model of metabolic syndrome, transition of steatosis to
            steatohepatitis was associated with hypoadiponectinemia, a
            mediator of hepatic fatty acid disposal pathways
            [<a href="http://www.informatics.jax.org/reference/J:107058">PMID:16516152</a>].
            </p>
            <a href="/model/MGI_3621984" class="btn btn-large btn-success">Find out more</a>
        </div>
        <div class="col-lg-9">
            <h1>Model List</h1>
            <ul>
                <li><a href="#">...</li>
            </ul>
        </div>
    </div>
</body>
</html>
